Publication

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Anne Marie Lennon, Johns Hopkins UniversityAdam H. Buchanan, GeisingerIsaac Kinde, Thrive Earlier Detection Corp.Andrew Warren, Thrive Earlier Detection Corp.Ashley Honushefsky, GeisingerAriella T. Cohain, Thrive Earlier Detection Corp.David H. Ledbetter, GeisingerAlfred Sanfilippo, Emory UniversityKathleen Sheridan, GeisingerDillenia Rosica, GeisingerChristian S. Adonizio, GeisingerHee Jung Hwang, Thrive Earlier Detection CorpKamel Lahouel, Johns Hopkins UniversityJoshua D. Cohen, Johns Hopkins UniversityChristopher Douville, Johns Hopkins UniversityAalpen A. Patel, GeisingerLeonardo N. Hagmann, Thrive Earlier Detection Corp.David D. Rolston, GeisingerNirav Malani, Thrive Earlier Detection Corp.Shibin Zhou, Johns Hopkins UniversityChetan Bettegowda, Johns Hopkins UniversityDavid L. Diehl, GeisingerBobbi Urban, Thrive Earlier Detect CorpChristopher D. Still, GeisingerLisa Kann, Thrive Earlier Detection Corp.Julie I. Woods, GeisingerZachary M. Salvati, GeisingerJoseph Vadakara, GeisingerRosemary Leeming, GeisingerPrianka Bhattacharya, GeisingerCarroll Walter, GeisingerAlex Parker, Thrive Earlier Detection Corp.Christoph Lengauer, Thrive Earlier Detection Corp.Alison Klein, Johns Hopkins UniversityCristian Tomasetti, Johns Hopkins UniversityElliot K. Fishman, Johns Hopkins UniversityRalph H. Hruban, Johns Hopkins UniversityKenneth W. Kinzler, Johns Hopkins UniversityBert Vogelstein, Johns Hopkins UniversityNickolas Papadopoulos, Johns Hopkins University
Language
  • English
Date
  • 2020-07-03
Publisher
  • American Association for the Advancement of Science
Publication Version
Copyright Statement
  • © 2020 American Association for the Advancement of Science. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 369
Issue
  • 6499
Start Page
  • 49
End Page
  • +
Grant/Funding Information
  • This work was supported by The Marcus Foundation; Lustgarten Foundation for Pancreatic Cancer Research; The Virginia and D.K. Ludwig Fund for Cancer Research;
  • The Sol Goldman Center for Pancreatic Cancer Research; Susan Wojcicki and Dennis Troper; the Rolfe Foundation; The Conrad R. Hilton Foundation;
  • The John Templeton Foundation; Burroughs Wellcome Career Award For Medical Scientists; ancillary support to investigators was provided by National Institutes of Health grants and contracts CA06973, U01-CA152753, U01-CA230691, P50-CA62924, R44CA203350, R37CA230400, T32-GM007309, and HHSN261201600034C.
Supplemental Material (URL)
Abstract
  • Cancer treatments are often more successful when the disease is detected early. We evaluated the feasibility and safety of multicancer blood testing coupled with positron emission tomography-computed tomography (PET-CT) imaging to detect cancer in a prospective, interventional study of 10,006 women not previously known to have cancer. Positive blood tests were independently confirmed by a diagnostic PET-CT, which also localized the cancer. Twenty-six cancers were detected by blood testing. Of these, 15 underwent PET-CT imaging and nine (60%) were surgically excised. Twenty-four additional cancers were detected by standard-of-care screening and 46 by neither approach. One percent of participants underwent PET-CT imaging based on false-positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multicancer blood testing combined with PET-CT can be safely incorporated into routine clinical care, in some cases leading to surgery with intent to cure.
Author Notes
Keywords
Research Categories
  • Health Sciences, Pathology
  • Biology, Biostatistics
  • Biology, Bioinformatics
  • Health Sciences, Oncology
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items